Skip to main content
Beam Therapeutics Inc. logo

Beam Therapeutics Inc. — Investor Relations & Filings

Ticker · BEAM ISIN · US07373V1052 US Manufacturing
Open in API
Filings indexed 457 across all filing types
Latest filing 2020-01-31 Regulatory Filings
Country US United States of America
Listing US BEAM

About Beam Therapeutics Inc.

https://beamtx.com/

Beam Therapeutics Inc. is a biotechnology company developing precision genetic medicines using its proprietary base editing technology. This approach is designed to make precise, single-letter edits to the genome without causing double-stranded breaks in the DNA, aiming to overcome the limitations of traditional gene editing methods. The company's pipeline focuses on creating potential life-long cures for genetic disorders, including sickle cell disease, beta-thalassemia, and alpha-1 antitrypsin deficiency. Beam Therapeutics is also advancing a suite of delivery technologies, such as electroporation, nonviral, and viral modalities, to deliver its base editors to target cells.

Recent filings

Filing Released Lang Actions
8-A12B
Regulatory Filings Classification · 100% confidence The document is a Form 8-A filed with the SEC, which is used for the registration of certain classes of securities under the Securities Exchange Act of 1934. It includes details about the registrant, the securities to be registered, and a signature from the CEO. There are no financial statements, earnings data, or management discussion. The document is a regulatory filing related to securities registration, not an annual report, earnings release, or other financial report. Therefore, it fits best under Regulatory Filings (RNS). The document length is under 5,000 characters and is a formal SEC filing form, confirming it is not a report but a regulatory filing.
2020-01-31 English
Regulatory Filings 2020
Regulatory Filings Classification · 95% confidence The document is a letter from legal counsel to the SEC Division of Corporation Finance regarding amendments to a Registration Statement on Form S-1 for Beam Therapeutics Inc. It discusses responses to SEC staff comments on financial calculations and legal provisions related to the offering of shares. The document is not a financial report, earnings release, or management discussion, but rather a regulatory filing related to securities registration and compliance. It does not contain financial statements or detailed financial analysis but is a correspondence filing with the SEC. Therefore, it fits best under Regulatory Filings (RNS). The document length (6965 characters) and content confirm it is not a report publication announcement or certification but a substantive regulatory correspondence.
2020-01-31 English
S-1/A
Regulatory Filings Classification · 100% confidence The document is a Form S-1/A Registration Statement Amendment No. 3 filed with the SEC for Beam Therapeutics Inc. It is a detailed registration statement for an initial public offering (IPO) of common stock. The text includes the SEC header, registration number, company details, offering details, underwriting information, risk factors, management discussion and analysis, business overview, and other sections typical of an S-1 filing. This is a regulatory filing related to securities registration and offering, not a financial report like an annual or quarterly report, nor an earnings release or management discussion standalone. It is not an announcement of a report but the actual registration statement document. The S-1 form is a registration statement under the Securities Act of 1933 and is classified under Regulatory Filings (RNS) in the given taxonomy because it does not fit into other categories like Annual Report, Earnings Release, or Capital/Financing Update. The document length and content confirm it is a full filing, not a brief announcement or certification.
2020-01-31 English
Regulatory Filings 2020
Regulatory Filings
2020-01-30 English
S-1/A
Regulatory Filings Classification · 95% confidence The document is a Form S-1/A Registration Statement Amendment No. 2 filed with the SEC, dated January 27, 2020. It is a registration statement under the Securities Act of 1933 for an initial public offering (IPO) of common stock by Beam Therapeutics Inc. The text includes detailed information typical of an IPO prospectus, such as risk factors, use of proceeds, capitalization, dilution, management discussion and analysis, business description, executive compensation, principal stockholders, underwriting, and legal matters. This type of filing is a registration statement for securities offering, not a financial report, earnings release, or other types of filings listed. The closest matching category in the provided list is Regulatory Filings (RNS), which is the fallback for miscellaneous filings that do not fit other categories, including SEC registration statements like Form S-1.
2020-01-27 English
Regulatory Filings 2020
Regulatory Filings Classification · 95% confidence The document is a correspondence letter from legal counsel to the SEC regarding an Amendment No. 1 to a Registration Statement on Form S-1 filed by Beam Therapeutics Inc. It includes responses to SEC staff comments on the Registration Statement, which relates to the offering of shares of common stock. The document is short (3518 characters) and primarily serves as a filing amendment and comment response rather than a financial report or detailed disclosure. It does not contain financial statements or substantive financial data, nor is it a report like an Annual Report or Interim Report. It is also not a report publication announcement since it contains substantive responses to regulatory comments. The document fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory correspondence and filings that do not fit other categories.
2020-01-17 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.